In this work, we show that combined (not separate) application of HBEGF and TNF (HT) in a human model system is sufficient to induce a complex pathology termed the HT-HRO model: PR degeneration and MG pathologies develop simultaneously as one dynamic phenotype (progressing from onset to endstage). This evidence concerns the gene TNF and myasthenia gravis.